NASDAQ:EYE

National Vision Holdings Stock News

etoro logo Buy EYE
*Your capital is at risk
$16.78
-0.180 (-1.06%)
At Close: Jun 23, 2026
Evaluate the expected performance of National Vision (EYE) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key met
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either National Vision (EYE) or L'Oreal SA (LRLCY). But which of these two stocks presents investors with
DULUTH, Ga.--(BUSINESS WIRE)--National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) will report its first quarter 2026 financial results before the market opens on
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Consumers aren't necessarily spending less, they're spending smarter. Retailers like Ollie's Bargain Outlet are winning because they meet people where they are right now.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
National Vision (EYE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Shares of National Vision Holdings, Inc. (NASDAQ: EYE - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the fourteen ratings firms that are currently covering the
EYE stock's rally reflects strategic transformation, market share gains, and expansion plans, but risks from debt and costs could test momentum.
National Vision (NASDAQ: EYE - Get Free Report) and Grocery Outlet (NASDAQ: GO - Get Free Report) are both consumer staples companies, but which is the better business? We will compare the two busines
National Vision rides on brand gains, Meta AI glasses rollout and hybrid care expansion, but high debt and macro cost pressures cloud the outlook despite strong momentum.
Primary and Key Secondary Endpoints Met 77% of Patients Achieved Highly Statistically Significant Proptosis Response Study Showed Clinically Meaningful Reduction in Proptosis; Greater Than 3 mm THOUSA
National Vision (EYE) reported earnings 30 days ago. What's next for the stock?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
National Vision Holdings is no longer a turnaround story—FY2025 results show robust growth, margin expansion, and improved customer mix. Managed care now drives 42% of revenue, with higher-value coh
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE